DM

Dheeraj M Nayak

Director DIN 08095753
DIN 08095753 First appointment Mar 2018
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Dheeraj M Nayak

Data last updated:

Dheeraj M Nayak was a Director at Cerebra Sciences Private Limited (from 2020) and Director at Pharmadroid Healthcare Solutions Private Limited (from 2018).

DIN 08095753
First Appointment 26 Mar 2018
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cerebra Sciences Private Limited U74999KA2020PTC132780
Director18 Feb 20202020Strike Off
Director26 Mar 20182018₹2.9 Lakh (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cerebra Sciences Private Limited
Pharmadroid Healthcare Solutions Private Limited
Premium access

Shareholding and investment profile for Dheeraj M Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dheeraj M Nayak

Dheeraj M Nayak was first appointed on 26 Mar 2018 as Director at Pharmadroid Healthcare Solutions Private Limited. The most recent appointment on record is 18 Feb 2020 at Cerebra Sciences Private Limited.

Dheeraj M Nayak held 2 earlier board appointments: Cerebra Sciences Private Limited (Director, from 18 Feb 2020); Pharmadroid Healthcare Solutions Private Limited (Director, from 26 Mar 2018).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available